Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes
2010 ◽
Vol 152
(6)
◽
pp. JC3
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 9
(2)
◽
pp. 139-145
◽
2000 ◽
Vol 89
(3)
◽
pp. 224-229
◽
Keyword(s):